VERTEX PHARMACEUTICALS INC / MA
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
EVP, CP and NPPO
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP & Chief Accounting Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Director
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
EVP, Chief Reg. & Quality Off.
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP Chief Patient & Ext Af Off
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
EVP, Chief Reg. & Quality Off.
Common Stock
EVP, Chief Commercial Officer
Common Stock
EVP and Chief Legal Officer
Common Stock
EVP and CMO
Common Stock
EVP and CMO
Common Stock
EVP and CMO
Common Stock
EVP and CMO
Common Stock
EVP and Chief Legal Officer
Common Stock
EVP and CMO
Common Stock
EVP, Chief Scientific Officer
Common Stock
EVP and CMO
Common Stock
EVP and CMO
Common Stock
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP, CP and NPPO | Common StockGrant or award | 8,682Award · no purchase price | Non-cash award | Sep 8Filed Sep 10 · 2d later | SEC filing |
| SVP & Chief Accounting Officer | Common StockGrant or award | 5,000Award · no purchase price | Non-cash award | Aug 28Filed Sep 1 · 4d later | SEC filing |
| Director | Common StockGift | 6,000Gift · no purchase price | Not a purchase | Aug 27Filed Aug 31 · 4d later | SEC filing |
| EVP, Chief Reg. & Quality Off. | Common StockGrant or award | 8,251Award · no purchase price | Non-cash award | Jul 21Filed Jul 23 · 2d later | SEC filing |
| EVP Chief Patient & Ext Af Off | Common StockGrant or award | 8,251Award · no purchase price | Non-cash award | Jul 21Filed Jul 23 · 2d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units100$475.28 / derivative unit | $47.5K | Jul 15Filed Jul 17 · 2d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units32$475.28 / derivative unit | $15K | Jul 15Filed Jul 17 · 2d later | SEC filing |
| EVP, Chief Reg. & Quality Off. | Common StockSale10b5-1 | 1,500$524.99 / share | $787.49K | Jul 2Filed Jul 7 · 5d later | SEC filing |
| EVP, Chief Commercial Officer | Common StockSale10b5-1 | 1,541$519.00 / share | $799.78K | Jul 2Filed Jul 7 · 5d later | SEC filing |
| EVP and Chief Legal Officer | Common StockSale10b5-1 | 828$502.71 / share | $416.24K | Jul 1Filed Jul 6 · 5d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 596$482.50 / share | $287.57K | Jun 26Filed Jun 30 · 4d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 1,020$462.17 / share | $471.41K | Jun 18Filed Jun 23 · 5d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 4,062$450.00 / share | $1.83M | Jun 15Filed Jun 17 · 2d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 1,745$450.00 / share | $785.25K | Jun 5Filed Jun 9 · 4d later | SEC filing |
| EVP and Chief Legal Officer | Common StockSale10b5-1 | 828$439.91 / share | $364.25K | Jun 1Filed Jun 3 · 2d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 1,974$450.00 / share | $888.3K | May 29Filed Jun 2 · 4d later | SEC filing |
| EVP, Chief Scientific Officer | Common StockSale10b5-1 | 33$453.45 / share | $14.96K | May 15Filed May 19 · 4d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 1,354$453.45 / share | $613.97K | May 15Filed May 19 · 4d later | SEC filing |
| EVP and CMO | Common StockSale10b5-1 | 6,988$450.00 / share | $3.14M | May 12Filed May 14 · 2d later | SEC filing |
| Director | Common StockDisposition to issuer | 796Price not reported | Unavailable | May 1Filed May 5 · 4d later | SEC filing |
Showing the latest 20 of 46 trades. Show all 46 trades
Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberVertex Pharmaceuticals Incorporated - Common Stock · Stock
The filing reports a full sale for a joint account.
Thomas H TubervilleReporting Senate memberVertex Pharmaceuticals Incorporated - Common Stock · Stock
The filing reports a purchase for the member.
Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberVertex Pharmaceuticals Incorporated - Common Stock (VRTX) · Stock
The filing reports a purchase for the member.
Julia LetlowReporting House member